Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Carsten Krieg; Malgorzata Nowicka; Silvia Guglietta; Sabrina Schindler; Felix J Hartmann; Lukas M Weber; Reinhard Dummer; Mark D Robinson; Mitchell P Levesque; Burkhard Becher

doi:10.1038/s41591-018-0094-7

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Nat Med. 2018 Nov;24(11):1773-1775. doi: 10.1038/s41591-018-0094-7.

Authors

Carsten Krieg^{1

2}, Malgorzata Nowicka^{3

4}, Silvia Guglietta⁵, Sabrina Schindler⁶, Felix J Hartmann⁷, Lukas M Weber^{3

4}, Reinhard Dummer⁶, Mark D Robinson^{3

4}, Mitchell P Levesque⁸, Burkhard Becher⁹

Affiliations

¹ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. [email protected].
² Department of Microbiology and Immunology and Department of Dermatology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA. [email protected].
³ Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
⁴ Swiss Institute of Bioinformatics (SIB), University of Zurich, Zurich, Switzerland.
⁵ Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
⁶ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
⁷ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
⁸ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. [email protected].
⁹ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. [email protected].

PMID: 29967347
DOI: 10.1038/s41591-018-0094-7

Abstract

In the version of this article initially published, Figs. 5a,c and 6a were incorrect because of an error in a metadata spreadsheet that led to the healthy donor patient 2 (HD2) samples being used twice in the analysis of baseline samples and in the analysis at 12 weeks of anti-PD-1 therapy, while HD3 samples had not been used.

Publication types

Published Erratum